Anti-Ribophorin I antibody [EPR17044(B)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal Ribophorin I antibody. Suitable for WB and reacts with Rat, Human samples. Cited in 3 publications.
View Alternative Names
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1, Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit, Ribophorin I, Ribophorin-1, RPN-I, RPN1
- WB
Lab
Western blot - Anti-Ribophorin I antibody [EPR17044(B)] (AB197888)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Ribophorin I antibody [EPR17044(B)] (ab197888) at 1/20000 dilution
Lane 1:
BxPC-3 (human Pancreas adenocarcinoma ) whole cell lysate at 20 µg
Lane 2:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 69 kDa
false
Exposure time: 1min
- WB
Lab
Western blot - Anti-Ribophorin I antibody [EPR17044(B)] (AB197888)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Ribophorin I antibody [EPR17044(B)] (ab197888) at 1/2000 dilution
Lane 1:
Rat kidney lysate at 10 µg
Lane 2:
Rat spleen lysate at 10 µg
Lane 3:
C6 (Rat glial tumor cells) whole cell lysate at 10 µg
Lane 4:
PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 69 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-Ribophorin I antibody [EPR17044(B)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Ribophorin I plays an essential role in the process of protein folding and quality control within the ER. It is part of the oligosaccharyltransferase complex along with other key proteins like STT3A/B and Ribophorin II. The complex ensures that nascent proteins receive the proper glycosylation necessary for proper folding and stability. This process helps maintain a balance between protein production and degradation ensuring that only properly folded proteins proceed to their intended cellular locations.
Pathways
Ribophorin I functions within the N-linked glycosylation pathway critical for protein maturation and function. Also it takes part in the unfolded protein response pathway which reacts to stress conditions that disrupt the folding processes in the ER. This pathway involves other proteins such as BiP/GRP78 and ATF6 which work together to restore normal protein folding conditions. Ribophorin I's efficient function in these pathways is key to sustaining cellular operations maintaining protein homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Aging 16:10997-11017 PubMed38968580
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 27:333-344 PubMed37386831
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy oncolytics 8:52-61 PubMed29511732
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com